Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)

Perrigo Company today announced that it has received final approval from the U.S. FDA to market Sulfacetamide Sodium Topical Suspension, 10% (Lotion).

The details can be read here.